Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Defective mismatch repair and the development of recurrent endometrial carcinoma.

Gynecologic oncology - 1 Aug 2004

Pijnenborg J M A, Dam-de Veen G C, de Haan J, van Engeland M, Groothuis P G

Abstract excerpt

OBJECTIVE: To investigate whether defective DNA mismatch repair (MMR) defines a subgroup at risk for recurrence in sporadic endometrial carcinoma patients. METHODS: Primary tumors from 44 patients with recurrent stage I endometrial carcinoma were compared after matching, with tumors of 44 patients being free of recurrence for minimal 3 years. Paraffin-embedded primary tumors (n = 88) and recurrent tumors (n = 32)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Base Pair Mismatch

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to MutL Protein Homolog 1

Share to MutS Homolog 2 Protein

Share to Neoplasm Proteins

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Source

Identifiers

PMID: 15297202
DOI: 10.1016/j.ygyno.2004.05.020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Defective mismatch repair and the development of recurrent endometrial carcinoma.PMID 15297202Read ↗

hMLH1 promoter hypermethylation and MSI status in human endometrial carcinomas with and without metastases.Semantic proximity Read ↗

The High Frequency of De novo Promoter Methylation in Synchronous Primary Endometrial and Ovarian CarcinomasSemantic proximity Read ↗

RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer.Semantic proximity Read ↗

Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.Semantic proximity Read ↗

High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas.Semantic proximity Read ↗

Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma.Semantic proximity Read ↗

Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.Semantic proximity Read ↗

Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinomaSemantic proximity Read ↗

Tissue Microarray Immunohistochemical Expression Analysis of Mismatch Repair (hMLH1 and hMSH2 Genes) in Endometrial Carcinoma and Atypical Endometrial Hyperplasia: Relationship with Microsatellite InstabilitySemantic proximity Read ↗

Endometrial Carcinomas With Subclonal Loss of Mismatch Repair ProteinsSemantic proximity Read ↗

Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer.Semantic proximity Read ↗

Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.